Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Arason, G JKramer, J
Blaskó, B
Kolka, R
Thorbjornsdottir, P
Einarsdottir, K
Sigfusdottir, A
Sigurdarson, S T
Sigurdsson, G
Rónai, Z
Prohászka, Z
Sasvari-Székely, M
Bodvarsson, S
Thorgeirsson, G
Füst, G
Issue Date
2007-06-07
Metadata
Show full item recordCitation
Clin Exp Immunol 2007, 149(1):132-38Abstract
We have demonstrated previously that carriers of a genotype called C4B*Q0 (silent allele of the C4B gene) have a substantially increased risk to suffer from myocardial infarction or stroke, and are selected out from the healthy elderly population. Because smoking carries a major risk for cardiovascular disease (CVD), it seemed worthwhile to study if these two factors interact. Study 1 involved 74 patients with angina pectoris (AP), 85 patients with recent acute myocardial infarction (AMI) and 112 survivors of a previous AMI and 382 controls from Iceland. Study 2 involved 233 patients with severe CVD and 274 controls from Hungary. Smoking habits were registered for each subject. The number of C4A and C4B genes was determined by phenotyping or genotyping. Compared to controls, C4B*Q0 carrier frequency was significantly higher at diagnosis in Icelandic smokers with AP (P = 0.005) and AMI (P = 0.0003) and Hungarian smokers with severe coronary artery disease (P = 0.023), while no such difference was observed in non-smoking subjects. Age-associated decrease in C4B*Q0 observed previously in two remote Caucasian populations was found, in the present study, to be associated strongly with smoking, and to already occur in smokers after age 50 years both in Iceland and Hungary. Our findings indicate that the C4B*Q0 genotype can be considered as a major covariate of smoking in precipitating the risk for AMI and associated deaths.Description
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldae974a485f413a2113503eed53cd6c53
10.1111/j.1365-2249.2007.03391.x
Scopus Count
Collections
Related articles
- Low complement C4B gene copy number predicts short-term mortality after acute myocardial infarction.
- Authors: Blaskó B, Kolka R, Thorbjornsdottir P, Sigurdarson ST, Sigurdsson G, Rónai Z, Sasvári-Székely M, Bödvarsson S, Thorgeirsson G, Prohászka Z, Kovács M, Füst G, Arason GJ
- Issue date: 2008 Jan
- Diseases associated with the low copy number of the C4B gene encoding C4, the fourth component of complement.
- Authors: Szilágyi A, Fust G
- Issue date: 2008
- ACTH-induced cortisol release is related to the copy number of the C4B gene encoding the fourth component of complement in patients with non-functional adrenal incidentaloma.
- Authors: Bánlaki Z, Raizer G, Acs B, Majnik J, Doleschall M, Szilágyi A, Rácz K, Füst G, Patócs A
- Issue date: 2012 Apr
- Genetic basis of tobacco smoking: strong association of a specific major histocompatibility complex haplotype on chromosome 6 with smoking behavior.
- Authors: Füst G, Arason GJ, Kramer J, Szalai C, Duba J, Yang Y, Chung EK, Zhou B, Blanchong CA, Lokki ML, Bödvarsson S, Prohászka Z, Karádi I, Vatay A, Kovács M, Romics L, Thorgeirsson G, Yu CY
- Issue date: 2004 Oct
- Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study.
- Authors: Sayed-Tabatabaei FA, Schut AF, Arias Vásquez A, Bertoli-Avella AM, Hofman A, Witteman JC, van Duijn CM
- Issue date: 2005 Jan